Austin Health

Title
A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy.
Publication Date
2022
Author(s)
Lim Joon, Daryl
Berry, Colleen
Harris, Benjamin
Tacey, Mark A
Smith, Drew
Lawrentschuk, Nathan
Schneider, Michal Elisabeth
Fraser, Olivia
Hall, Megan
Chao, Michael
Foroudi, Farshad
Jenkins, Trish
Angus, David
Wada, Morikatsu
Sengupta, Shomik
Khoo, Vincent
Subject
image guided radiotherapy
polymer fiducials
prostate cancer
radiotherapy
verification
Type of document
Journal Article
OrcId
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.3389/fonc.2022.1023288
Abstract
Image guidance with gold fiducials improves outcomes of prostate radiotherapy. However, gold produces artefact on CT imaging, interfering with contouring and verification. The purpose of this study was to compare polymer to standard gold fiducials using radiotherapy imaging modalities to assess the visibility and artefact.
Link
link
Citation
Frontiers in Oncology 2022; 12
Jornal Title
Frontiers in Oncology

Files:

NameSizeformatDescriptionLink